MPS I: Early diagnosis, bone disease and treatment, where are we now?

Abstract excerpt

Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disorder characterized by α-L-iduronidase deficiency. Patients present with a broad spectrum of disease severity ranging from the most severe phenotype (Hurler) with devastating neurocognitive decline, bone disease and early death to intermediate (Hurler-Scheie) and more attenuated (Scheie) phenotypes, with a normal life expectancy. The most severely...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bone Diseases
• Share to Disease Management
• Share to Early Diagnosis